David H Deming

CIK 1641063 · last filed 2026-02-06

David H Deming is a corporate insider who has filed 18 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for PHIO, was dated Feb 6, 2026. Current disclosed insider exposure totals $40.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$40.4K

Companies

3

Total Filings

18

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PHIO Director 37,800 $1.07 $40.4K $0 2 2026-02-06
SRNE Director $0.00 $0 4 2017-09-18
ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted Director 6,838 $0 2 2017-02-10

Recent Filings

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-06 PHIO Grant (A) +23,800 $0 EDGAR
2025-09-15 PHIO Grant (A) +14,000 $0 EDGAR
2024-03-06 Grant (A) +5,345,271 $0
2023-06-12 Grant (A) +25,000 $0
2023-03-31 Grant (A) +25,000 $0
2023-03-28 Grant (A) +25,000 $0
2022-09-01 Grant (A) +25,000 $0
2022-07-13 Grant (A) +25,000 $0
2022-04-13 Grant (A) +25,000 $0
2022-01-05 Grant (A) +25,000 $0
Showing 110 of 18
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.